NCT04047186CompletedPhase 2
Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules
Neoadjuvant Anti-PD-1 Therapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules: a Pilot Study
Source: ClinicalTrials.gov · Last updated 23 Sept 2025
Brief summary (registry, in English)
Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules: a pilot study
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 4 Aug 2019
- Start date
- 1 Jul 2019
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- XiangNing Fu
- Diseases
- Lung cancer
- NCT number
- NCT04047186
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 12
- From 1 Jul 2019 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- received or receiving chemo- and radiotherapy
Other illness
- medical history of malignancy
- severe organ failure (heart, liver, kidney, and lung)
- infection out of control
- history of severe reaction due to allergy or hypersensitivity
- severe mental disorder
- autoimmune or chronic inflammatory disease
Other
- pregnant or breeding period
- high risk of cerebral-cardiovascular evens
- currently been enrolled in other trials
Who the study is looking for
- not less than two GGNs on chest CT
- at least one lesion is diagnosed as NSCLC from biopsy pathology
- no contraindication for surgery
- ECOG score of 0 or 1
- no detectable evidence of distant metastasis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji Hospital Affiliated to Huazhong Technology Hospital Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.